BCAB vs DTE
Bioatla Inc (BCAB) versus DTE (DTE) — a side-by-side from cached financials, not a winner call.
Bioatla Inc (BCAB) is a biotechnology company listed on NASDAQ.
DTE (DTE) common stock.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
DTE does not have a complete income-statement cache yet.
BCAB currently screens at market cap $5.9M. DTE currently screens at market cap $0.
Not investment advice. Open the BCAB and DTE stock pages for the full models.
Not investment advice.